Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date

References

• HiattWRHoagSHammanRFEffect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes StudyCirculation1995915147214797867189
   PubMed Web of Science ®Google Scholar
• NorgrenLHiattWRDormandyJATASC II Working GroupInter-society consensus for the management of peripheral arterial disease (TASC II)J Vasc Surg200745Suppl SS5S6717223489
   PubMed Web of Science ®Google Scholar
• European Stroke OrganisationTenderaMAboyansVESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC)Eur Heart J201132222851290621873417
   PubMed Web of Science ®Google Scholar
• ChalmersNWalkerPTBelliAMRandomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER studyCardiovasc Intervent Radiol201336235336123070104
   PubMed Web of Science ®Google Scholar
• LohJPBarbashIMWaksmanRThe current status of drug-coated balloons in percutaneous coronary and peripheral interventionsEuro-Intervention20139897998824384294
   PubMedGoogle Scholar
• ZellerTSchmitmeierSTepeGDrug-coated balloons in the lower limbJ Cardiovasc Surg (Torino)2011522235243
   PubMed Web of Science ®Google Scholar
• SchellerBSpeckUAbramjukCBernhardtUBöhmMNickenigGPaclitaxel balloon coating, a novel method for prevention and therapy of restenosisCirculation2004110781081415302790
   PubMed Web of Science ®Google Scholar
• SchellerBThe Invatec IN-PACT Falcon paclitaxel DEB: device description and clinical studiesPresented at: Transcatheter Cardiovascular TherapeuticsSeptember 21–25, 2010Washington, DC
   Google Scholar
• HigginsJPAltmanDGOn Behalf of the Cochrane Statistical Methods Group the Cochrane Bias Methods GroupCochrane Handbook for Systematic Reviews of InterventionsVersion 501 Chapter 8: Assessing risk of bias in included studiesLondonJohn Wiley and Sons, Ltd2008 Available from: http://handbook.cochrane.org/chapter_8/8_assessing_risk_of_bias_in_included_studies.htmAccessed January 28, 2016
   Google Scholar
• GuyattGHOxmanADVistGEGRADE Working GroupGRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ2008336765092492618436948
   PubMed Web of Science ®Google Scholar
• RosenfieldKJaffMRWhiteCJLEVANT 2 InvestigatorsTrial of a paclitaxel-coated balloon for femoropopliteal artery diseaseN Engl J Med2015373214515326106946
   PubMed Web of Science ®Google Scholar
• TepeGLairdJSchneiderPIN.PACT SFA Trial Investigators. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trialCirculation2015131549550225472980
   PubMed Web of Science ®Google Scholar
• FanelliFCannavaleABoattaELower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trialJ Endovasc Ther201219557158023046320
   PubMed Web of Science ®Google Scholar
• ScheinertDDudaSZellerTThe LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplastyJACC Cardiovasc Interv201471101924456716
   PubMed Web of Science ®Google Scholar
• LiistroFGrottiSPortoIDrug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery)JACC Cardiovasc Interv20136121295130224239203
   PubMed Web of Science ®Google Scholar
• WerkMAlbrechtTMeyerDRPaclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trialCirc Cardiovasc Interv20125683184023192918
   PubMed Web of Science ®Google Scholar
• TepeGZellerTAlbrechtTLocal delivery of paclitaxel to inhibit restenosis during angioplasty of the legN Engl J Med2008358768969918272892
   PubMed Web of Science ®Google Scholar
• WerkMLangnerSReinkensmeierBInhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trialCirculation2008118131358136518779447
   PubMed Web of Science ®Google Scholar
• CasseseSByrneRAOttIPaclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trialsCirc Cardiovasc Interv20125458258922851526
   PubMed Web of Science ®Google Scholar
• BaerlocherMOKennedySARajebiMRMeta-analysis of drug-eluting balloon angioplasty and drug-eluting stent placement for infrainguinal peripheral arterial diseaseJ Vasc Interv Radiol201526445947325703839
   PubMed Web of Science ®Google Scholar
• SchmidtAPiorkowskiMWernerMFirst experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcomeJ Am Coll Cardiol201158111105110921884945
   PubMed Web of Science ®Google Scholar
• SiablisDKitrouPMSpiliopoulosSPaclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trialJACC Cardiovasc Interv2014791048105625234679
   PubMed Web of Science ®Google Scholar
• LiistroFPortoIAngioliPDrug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemiaCirculation2013128661562123797811
   PubMed Web of Science ®Google Scholar
• ZellerTBaumgartnerIScheinertDIN.PACT DEEP Trial Investigators. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trialJ Am Coll Cardiol201464151568157625301459
   PubMed Web of Science ®Google Scholar
• ISRCTN14469736 [webpage on the Internet]The BASIL-3 Trial: Balloon vs Stenting in Severe Ischaemia of the Leg-3 Available from: http://www.isrctn.com/ISRCTN14469736Accessed January 28, 2016
   Google Scholar
• NCT02051088 [webpage on the Internet]The SWEDEPAD trial: Swedish Drug-elution Trial in Peripheral Arterial Disease. NCT02051088 Available from: https://clinicaltrials.gov/ct2/show/NCT02051088Accessed January 28, 2016
   Google Scholar
• NCT02563535 [webpage on the Internet]The ACOART-BTK trial: Evaluation of the Use of ACOTEC Drug-Eluting Balloon Litos^® in Below-The-Knee Arteries to Treat Critical Limb Ischemia. NCT02563535 Available from: https://clinicaltrials.gov/show/NCT02563535Accessed January 28, 2016
   Google Scholar
• NCT02540018 [webpage on the Internet]The EffPac trial: Effectiveness of Paclitaxel-coated Luminor^® Balloon Catheter Versus Uncoated Balloon Catheter in the Arteria Femoralis Superficialis. NCT02540018 Available from: https://clinicaltrials.gov/show/NCT02540018Accessed January 28, 2016
   Google Scholar
• NCT02129634 [webpage on the Internet]The SINGA-PACLI trial: Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia. NCT02540018 Available from: https://clinicaltrials.gov/show/NCT02129634Accessed January 28, 2016
   Google Scholar
• ThomasSDMcDonaldRRVarcoeRLVasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloonJ Vasc Surg201459252052323642919
   PubMed Web of Science ®Google Scholar